Showing results (71-80 of 450) with videos related to
Sort By:
Pageof 45
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 30, 2000
Tumour immunotherapy: the adjuvant treatment of the 21st century?A J Bremers, P J Kuppen, G ParmianiInternational Journal of Cancer|October 15, 1986
Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon gammaA Anichini, R Mortarini, G Fossati, et al.International Journal of Cancer|September 15, 1990
Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA profile and invasive abilityA Anichini, R Mortarini, R Supino, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Mouse tumors are heterogeneous in their susceptibility to syngeneic lymphokine-activated killer cells and delineate functional subsets in such effectorsM Sensi, L Grazioli, M Rodolfo, et al.International Journal of Clinical & Laboratory Research|January 1, 1997
T-cell recognition of melanoma antigens and its therapeutic applicationsC Castelli, L Rivoltini, A Mazzocchi, et al.Melanoma Research|August 1, 1991
An autologous T cell clone overcomes intra-melanoma heterogeneity for susceptibility to cell-mediated lysis by using multiple lytic mechanisms: in vitro and in vivo analysisA Mazzocchi, M Rodolfo, G Parmiani, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acidG Pratesi, M Rodolfo, G Rovetta, et al.European Journal of Immunology|October 1, 1998
Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cellsZ Wang, F Arienti, G Parmiani, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1991
Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: the pattern of in vitro reactivity predicts the in vivo effect on different tumoursM Rodolfo, C Bassi, C Salvi, et al.International Journal of Cancer|April 1, 1994
Multiple sub-sets of CD4+ and CD8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profilesC Maccalli, R Mortarini, G Parmiani, et al.Pageof 45